GLP-1 Medication Lawsuit Canada — Were You Harmed?
Canadians harmed by any GLP-1 medication — including Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, and Mounjaro — may qualify for a free legal case review.
- Free case review — no fees unless you recover
- All GLP-1 medications covered
- Serving all Canadian provinces and territories
13
Provinces & territories served
100%
Free case review
0
Upfront fees
Free Case Review — No Obligation
See If Your Experience May Qualify For Review
Answer a few quick questions. It takes about 2 minutes.
Step 1 of 3
By submitting, you consent to be contacted about your claim and agree to our Privacy Policy & Terms.
What Are GLP-1 Receptor Agonists?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic the GLP-1 hormone, which plays a role in regulating blood sugar and appetite. They are used to treat type 2 diabetes and, increasingly, for weight management.
GLP-1 medications work partly by slowing gastric emptying — the rate at which the stomach empties its contents into the small intestine. This slowing effect is central to how they reduce appetite and control blood sugar, but it is also believed to be the mechanism behind some serious adverse events including gastroparesis and bowel obstruction.
In Canada, GLP-1 medications are among the most widely prescribed drugs in recent years. Their widespread use has led to a growing number of reports of serious gastrointestinal complications, triggering regulatory reviews by Health Canada and legal inquiries across the country.
GLP-1 Medications Involved in Canadian Claims
If you took any of the following medications and experienced a serious side effect, you may have grounds for a claim.
| Drug Name | Action |
|---|---|
| Ozempic | Check eligibility → |
| Wegovy | Check eligibility → |
| Foundayo | Check eligibility → |
| Mounjaro | Check eligibility → |
| Rybelsus | Check eligibility → |
| Victoza | Check eligibility → |
| Saxenda | Check eligibility → |
| Trulicity | Check eligibility → |
| Byetta | Check eligibility → |
GLP-1 Side Effects That May Lead to a Claim
These are the most commonly cited serious adverse effects in GLP-1 medication legal proceedings.
Gastroparesis
A condition where the stomach cannot empty itself normally, causing nausea, vomiting, bloating, and severe abdominal pain. GLP-1 medications slow gastric motility and have been linked to gastroparesis.
Stomach Paralysis
Closely related to gastroparesis, stomach paralysis refers to the stomach's inability to contract and move food into the small intestine. It can cause serious nutritional complications.
Bowel Obstruction
Reports of ileus (temporary bowel paralysis) and bowel obstruction have emerged in patients using GLP-1 medications. These can be life-threatening without prompt treatment.
Vision Loss
Emerging research has associated GLP-1 receptor agonists with non-arteritic anterior ischemic optic neuropathy (NAION), a serious condition that can cause irreversible vision loss.
Severe GI Symptoms
Beyond gastroparesis, some patients report severe nausea, vomiting, diarrhea, and abdominal pain that required hospitalization or led to significant weight loss and malnutrition.
Other Serious Effects
Pancreatitis, kidney injury, and other serious complications have also been reported. If you experienced a serious adverse event after taking a GLP-1 medication, you may qualify.
How the Case Review Process Works
Getting a case review is straightforward and costs nothing. Here is what to expect.
Answer a Few Questions
Complete our short qualification form. It takes about two minutes. We ask about the medication you took, the side effects you experienced, and your province of residence.
We Review Your Information
Your information is reviewed against our qualification criteria. If your situation may qualify, your details are forwarded to a licensed legal service provider for a free, confidential case review.
Speak With a Case Reviewer
A qualified legal professional contacts you to learn more about your situation. There is no obligation and no fee to speak with them. If they take your case, you typically pay nothing unless there is a recovery.
Your Questions Answered
Common questions about GLP-1 injury claims in Canada.
No. GLP-1 Compensation is a legal lead generation and intake platform. We are not a law firm and we do not provide legal advice. We connect Canadians who may have been harmed by GLP-1 medications with licensed legal service providers who can evaluate their potential claims.
No. Submitting your information through this site does not create an attorney–client relationship. A lawyer–client relationship is only established once you have formally retained a lawyer and both parties have agreed to the representation.
The most common drugs in current Canadian inquiries are Ozempic (semaglutide) and Wegovy (semaglutide). Other GLP-1 medications including Rybelsus, Victoza, Saxenda, and Mounjaro may also be relevant depending on your specific situation.
Commonly reported qualifying injuries include gastroparesis (stomach paralysis), bowel obstruction, severe gastrointestinal symptoms requiring hospitalization, vision loss (including NAION), and other serious adverse events. Each case is reviewed individually — our form will ask about your specific situation.
No. The case review process through GLP-1 Compensation is free and carries no obligation. Legal professionals in our network typically work on contingency — meaning you pay nothing unless your case results in a recovery.
Yes. Each province has its own limitation period for personal injury claims, typically ranging from one to two years from when you knew or should have known about the potential claim. We strongly encourage you to submit your information promptly so a legal professional can advise you on any deadlines that may apply to your situation.
Were You Harmed by a GLP-1 Medication?
No matter which GLP-1 drug you took, if you experienced a serious side effect, you may be entitled to compensation. Start your free case review.
- You took Ozempic, Wegovy, or another GLP-1 medication
- You experienced a serious side effect
- You are a resident of Canada
- You have not yet retained a lawyer for this matter
Free case review · No obligation · No upfront fees
Legal Notice
GLP-1 Compensation is a legal referral and intake service — not a law firm — and does not provide legal advice. No lawyer–client relationship is formed by submitting information, calling any number on this site, or any other communication with us; such a relationship arises only upon formal written retainer with a licensed lawyer. Information submitted may be shared with licensed legal professionals in our referral network for case review.
Individual results vary. Qualifying for a case review does not guarantee a valid legal claim, legal representation, or any compensation. All claims are subject to applicable provincial limitation periods and other legal requirements.
This page does not constitute medical advice and is not a substitute for professional healthcare guidance. Do not discontinue, modify, or adjust any prescribed GLP-1 medication — including Ozempic, Wegovy, or Mounjaro — without first consulting your prescribing physician or healthcare provider.
Information on this site is for general informational purposes only and should not be relied upon as legal advice or as a substitute for advice from a qualified lawyer licensed in your province or territory. This site is intended solely for Canadian residents.